China Signals Commercial Insurance, Biotech And Foreign-Owned Hospitals As Policy Priorities

New Category C Drug List

Policy plans, goals and actions in 2025
China's 2025 government work report reiterated its focus on commercial insurance for innovative drugs, biotech and wholly foreign-owned hospitals. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from China

More from Pink Sheet